2023-507728-22-00Active, not recruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous Glofitamab following Obinutuzumab Pretreatment in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Sept 2026
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 73 (estimated)
- First submitted
- 23 May 2024
- Start date
- 25 Jun 2021
- Lead sponsor
- F. Hoffmann-La Roche AG
- Diseases
- Hodgkin lymphoma
- EU CT number
- 2023-507728-22-00
- EudraCT number
- 2021-000064-29
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 73
- 11 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Active, not recruiting |
| Rigshospitalet | Copenhagen Oe | Denmark | Active, not recruiting |
| Hospital Germans Trias i Pujol | Badalona | Spain | Active, not recruiting |
| Hospital Clinic de Barcelona | Barcelona | Spain | Active, not recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Active, not recruiting |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | Active, not recruiting |
| Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII | Bergamo | Italy | Active, not recruiting |
| Humanitas Mirasole S.p.A. | Rozzano | Italy | Active, not recruiting |
| Uniwersyteckie Centrum Kliniczne | Gdansk | Poland | Active, not recruiting |
| Uniwersytecki Szpital Kliniczny w Poznaniu | Poznan | Poland | Active, not recruiting |
| Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu | Wroclaw | Poland | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.